Karin Vanderkerken

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Bone marrow stromal cell–derived exosomes as communicators in drug resistance in multiple myeloma cells

Jinheng Wang, An Hendrix, Sophie Hernot et al. · Blood · 2014 · 445 citations

Medicine, Cell Biology, Oncology +16

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche

Michelle A. Lawson, Michelle M. McDonald, Nataša Kovačić et al. · Nature Communications · 2015 · 393 citations · Full text

Medicine, Cell Biology, Oncology +17

Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features

Abdel Kareem Azab, Jinsong Hu, Phong Quang et al. · Blood · 2012 · 299 citations · Full text

Medicine, Cancer Biology, Oncology +14

Zoledronic Acid Treatment of 5T2MM-Bearing Mice Inhibits the Development of Myeloma Bone Disease: Evidence for Decreased Osteolysis, Tumor Burden and Angiogenesis, and Increased Survival

Peter I. Croucher, Hendrik De Raeve, Mark Perry et al. · Journal of Bone and Mineral Research · 2003 · 267 citations · Full text

Medicine, Oncology, Pharmacology +17